Skip to main content
Premium Trial:

Request an Annual Quote

Nanosphere Shares Fall for Second Straight Day

NEW YORK (GenomeWeb News) – Shares of Nanosphere were down 6.1 percent at $9.09 in Monday afternoon trading on the Nasdaq, marking the second day in a row that its stock tumbled since it reported a 62 percent decrease in second-quarter revenues last week.
The Northbrook, Ill.-based molecular diagnostics firm reported last Thursday that its second-quarter revenue dropped to $195,000 from $510,000 in the second quarter of 2007. The firm also said that its net loss grew 17 percent year over year.
In Friday trade, Nanosphere’s stock fell 14.6 percent to close at $9.68.
The firm’s stock is trading well off a 52-week high of $22.04, which was reached in November 2007. Its 52-week low is $6.62, which it hit on May 5.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.